For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.
He first came into contact with the stock market and shares during his banking apprenticeship. After completing this in 2000, he gained his first journalistic experience in the editorial department of a financial portal. During his subsequent studies in business administration, he also worked in the area of investor relations.
Since then, he has remained true to the capital markets and is excited to report on every newly discovered interesting story - as well as on long-standing success stories.
Commented by Fabian Lorenz
Commented by Fabian Lorenz on August 11th, 2022 | 11:26 CEST
Alarm at Plug Power, problems for Nordex is good for Alpha Copper
It is the summer of renewable energy stocks. Russia's attack on Ukraine, high oil and gas prices, and climate change are just a few arguments why investors are so electrified by the sector. However, there is also a lot of advance praise being handed out. That is the case with Plug Power. When a company makes more losses than sales, alarm bells start ringing. But the Plug Power share is taking this surprisingly well. According to analysts, Nordex continues to suffer from high purchase prices, and an impending copper shortage will not reduce the problems. Alpha Copper should benefit from scarce copper. Drilling programs are giving the share a tailwind.
Read
Commented by Fabian Lorenz on August 10th, 2022 | 10:18 CEST
BioNTech, BYD, Altech Advanced Materials: Excitement is rising
So much for the summer slump. The stock markets are generally friendly at the moment, and many shares are reacting with significant price swings to news, both negative and positive. Like with BioNTech, the share price fell sharply after an impressive rally after the quarterly figures. There are good reasons for rising prices in the coming weeks. BYD is also going full throttle operationally. The e-car manufacturer is reporting one sales record after another, and details are emerging about the launch in Germany to knock Tesla off its electric throne. E-cars, possibly also from BYD, are expected to incorporate battery technology from Altech Advanced Materials in the future. The Company is working on revolutionary technology, and new details are expected by the time of the AGM.
Read
Commented by Fabian Lorenz on August 4th, 2022 | 14:31 CEST
BYD chases Tesla, First Hydrogen is undervalued, and ITM Power with a buy signal
Hardly any other industry has such excellent prospects for the future as renewable energies. Whether electric mobility or hydrogen - all technologies are urgently needed and promoted. Among others, e-car manufacturer BYD is benefiting from this. In China, the Company is shining with significantly increasing sales figures and is on its way to knocking Tesla off its throne as the number 1 in the industry. It could happen faster than expected, as the Company plans to open its first showrooms in Germany and Sweden as early as October. ITM Power is overshadowed by Nel and Plug Power in the hydrogen sector. Analysts see a share price potential of over 100%. First Hydrogen also has potential. Analysts are currently observing the hydrogen newcomer's rise to the top tier and say there is an undervaluation compared to peer group company McPhy Energy.
Read
Commented by Fabian Lorenz on August 3rd, 2022 | 10:50 CEST
Varta at EUR 64 or EUR 102? Will BioNTech and Kleos Space make the breakout?
The stock market environment is currently friendly, and technology stocks, in particular, are in a recovery rally. Investors are driven by the hope that inflation will weaken and that an end to the interest rate increase cycle of the US Federal Reserve will at least become foreseeable. If this were the case, we would not be in a bear market rally, but at the beginning of a new bull market. But not all stocks have been able to benefit from the good mood in recent weeks. Rightly so? In the case of Varta, the answer is yes - the Company shocked shareholders with a profit warning on Saturday. However, the price targets of analysts diverge significantly. The BioNTech share is unusually quiet. There is positive news from the Company itself and its partner Pfizer. With the quarterly figures next week, an attempt to break out of the sideways trend could take place. Kleos Space is also currently making this attempt. Investors are positioning themselves with the high-tech company in preparation for the next milestone.
Read
Commented by Fabian Lorenz on July 28th, 2022 | 14:39 CEST
Is Elon Musk making a move on Standard Lithium? News from Newmont and Tocvan Ventures
The sentiment of investors in lithium and gold stocks could hardly be more different at the moment. Shares such as Standard Lithium and Livent are recovering significantly from their interim phase of weakness. The entire sector is benefiting from positive comments by Tesla founder Elon Musk. There is also speculation that the wealthiest man in the world could take a stake in Standard Lithium. It would make perfect sense for Tesla. In contrast, all hope seems to be fading in the gold sector. Heavyweights like Barrick Gold and Newmont are trading near 52-week lows. The latest setback was Newmont's numbers. However, the dividend yield is now tempting, and there are also positives from the gold sector. Canadian explorer Tocvan Ventures reported convincing drill results.
Read
Commented by Fabian Lorenz on July 27th, 2022 | 11:45 CEST
Opportunity for BYD, Plug Power and dynaCERT? Russia turns on the gas tap
Since yesterday, significantly less gas is flowing through the Nord Stream 1 pipeline to Germany. Russia is thus currently supplying only 20% of the possible capacity, showing again how unreliable Russia is and how dependent Western Europe - especially Germany is. On the other hand, it shows how important it is to promote alternative energies and energy efficiency, which means opportunities for companies like BYD, Plug Power and dynaCERT. Chinese carmaker BYD wants to expand its battery production and analysts see over 100% share price potential. dynaCERT could be due for a revaluation due to certification. Plug Power shareholders are currently watching the discussion about the government subsidy for hydrogen in the USA with bated breath.
Read
Commented by Fabian Lorenz on July 21st, 2022 | 11:34 CEST
Buy now? BioNTech, Nordex and MAS Gold
The mood on the world's stock markets has stabilized in recent days. Hopes are alive that inflation and the US dollar have seen their highs for now. Even a soft landing of the US economy is no longer ruled out. Therefore, for example, JPMorgan and Goldman Sachs advise buying shares because, from the perspective of the US banks, the chances of a V-shaped recovery of the stock markets are increasing. That could benefit stocks that have fallen by the wayside in recent months, including BioNTech. The Wiesbaden-based Company could be in for an exciting fall. A weaker US dollar would give a boost to the gold price. Gold explorer MAS Gold should be able to profit from this. Nordex has at least full coffers after two capital increases but continues to have problems. However, Jefferies advises buying.
Read
Commented by Fabian Lorenz on July 20th, 2022 | 13:18 CEST
Nel with a liberation blow - When will Varta and Almonty Industries take off?
Nel has long been one of the hopefuls in the hydrogen sector. But recently, Plug Power had somewhat outstripped the Norwegians. The reason: a lack of major orders at Nel to justify its billion-euro valuation. The major order has now finally arrived, and the stock is stepping on the gas. Since Monday, it has already gained more than 10%, and analysts see further room for improvement. It should also boost other shares along the renewable energy value chain: For example, battery manufacturer Varta and raw material producer Almonty Industries. Almonty, which is actually on its way to becoming the largest tungsten producer outside China, has published convincing estimates for a molybdenum project. With Varta, on the other hand, caution is the order of the day. The chart is battered and another insider sale adds to the uncertainty.
Read
Commented by Fabian Lorenz on July 14th, 2022 | 12:35 CEST
Nel successful in Australia, Rheinmetall recommended by Goldman and Barsele Minerals for the gold comeback
Interest rate fears, a looming recession and war in Ukraine - There are numerous reasons for nervousness on the stock market. But especially in uncertain times, the chances of long-term price gains are high. But where is the safe haven at the moment? Gold, renewable energies or even armaments? Gold is undoubtedly one of the disappointments of the year. The strong US dollar is weighing on the sector. But gold stocks are cheap. Alongside heavyweights, there are also explorers such as Barsele Minerals, and the Canadians bring takeover fantasy. Golden times are predicted for companies in the renewable energy sector. Hydrogen specialist Nel shines with an order from Australia. And defense companies like Rheinmetall are facing a super cycle. At the same time, the MDAX group is also getting involved in fuel cells, and Goldman Sachs advises buying.
Read
Commented by Fabian Lorenz on July 13th, 2022 | 14:27 CEST
MorphoSys facing a takeover? Exciting autumn ahead for BioNTech and XPhyto
Biotech investors could be in for an exciting autumn. After some sharp price corrections, positive things are happening again in the biotech sector. For one thing, the takeover carousel. It all started in June when Pfizer announced the acquisition of migraine specialist Biohaven for USD 11.6 billion, and GlaxoSmithKline plans to swallow Sierra Oncology for around USD 1.9 billion. Recent deals include the acquisitions of ViaCyte, La Jolla Pharmaceutical and Pliant Therapeutics. MorphoSys is also a possible takeover candidate. It could be a win-win for the German biotech company if the price is attractive. Xphyto could also see at least one investment, as a market-ready product has great potential.
Read